Australian Consumer Services Stock News

NEXTDC recently reported an approximately 11% increase in pro forma contracted utilisation to 740MW as of June 2026, underpinned by substantial new customer contract wins. To support this demand, the company raised about A$1.50 billion in new equity and expanded its senior debt facilities by A$2.30 billion, providing very large funding capacity for rapid digital infrastructure and AI-focused project build-outs. We’ll now examine how this surge in contracted utilisation reshapes NEXTDC’s...

As Australian shares surge, buoyed by global tech rallies and a positive outlook for the ASX 200, investors are keenly eyeing opportunities in dividend stocks that offer attractive yields. In such a dynamic market environment, selecting dividend stocks with strong fundamentals can provide potential income stability amidst broader market fluctuations.

As Australian shares surge into positive territory, buoyed by a global tech rally led by historic gains in the U.S. markets, investor attention is increasingly turning towards growth companies with substantial insider ownership on the ASX. In times of market optimism, stocks that demonstrate strong insider confidence can be particularly appealing, as they often suggest alignment between management and shareholder interests.

As Australian shares rally, driven by a historic surge in global tech stocks, the ASX 200 futures are poised to rise significantly, reflecting positive sentiment across major indices. In this buoyant market environment, identifying undervalued stocks that trade below their intrinsic value can offer potential opportunities for investors seeking to capitalize on discrepancies between current market prices and fundamental valuations.

Australian shares are poised for a strong performance, with the ASX 200 futures indicating a significant rise following global market trends driven by tech sector gains. For investors interested in exploring smaller or newer companies, penny stocks—though an older term—remain relevant and can offer intriguing opportunities. These stocks, when backed by solid financial health, may present potential for growth while mitigating some of the typical risks associated with this investment area.

Global inflation, interest rate uncertainty and uneven growth across regions have pushed many investors to pay closer attention to steady income rather than chasing fast-moving stories. That is where Dividend Powerhouses 3%+ Yield stocks can help. The screener focuses on companies with dividend yields above 5% that appear well covered, growing and relatively stable, which can be appealing when bond markets and energy prices are pulling sentiment in different directions. In this article, you...

Macquarie Group (ASX:MQG) is back in focus after announcing that Chief Executive Officer Shemara Wikramanayake will retire in November, with long-serving executive Greg Ward set to take over, subject to regulatory approvals. See our latest analysis for Macquarie Group. At a share price of A$253.09, Macquarie Group has a 90 day share price return of 6.26% and a year to date share price return of 24.23%. The 5 year total shareholder return of 90.80% points to sustained longer term gains, and...

Founders who still run their companies often think and act differently from hired executives. In a world where bond yields, inflation expectations and central bank paths are all pulling investor attention in different directions, founder-led stocks provide a way to focus on alignment instead of short term noise. These leaders usually hold significant personal stakes and tend to be deeply invested in the company’s long term legacy. This article looks at why that matters in the current macro...

Global markets are being pulled in different directions by inflation pressures, higher bond yields and shifting central bank signals. In this setting, investors often look for companies that are expected to grow earnings strongly while still keeping balance sheets in reasonable shape. That is exactly what the Healthy high growth potential screener aims to filter for. It focuses on stocks where analysts see solid earnings growth over the next 3 years and where financial foundations are not...

Rare earth metal stocks sit at the crossroads of clean energy, advanced technology and defense at a time when inflation, energy costs and geopolitics are shaping policy decisions around the world. With central banks reacting to energy prices and many countries facing budget pressure, access to critical minerals used in electric vehicles, high tech gear and military systems has become a key theme for investors. This Rare Earth Metal Stocks screener filters for companies directly mining these...

In July 2026, Telix Pharmaceuticals reported positive Phase 1 ProstACT SELECT data for its PSMA-targeting rADC TLX591-Tx, dosed the first patient in the Phase 3 LUTEON trial for TLX250-Tx in clear cell renal cell carcinoma, entered a collaboration with Regeneron Pharmaceuticals on radiopharmaceutical therapies, and raised its Fiscal Year 2026 revenue guidance to above US$1 billion alongside higher quarterly revenue of US$247 million. Together, these updates underscore Telix's attempt to...

Artificial intelligence stocks sit at the crossroads of powerful themes that many investors are watching today. Inflation, interest rates and energy markets are all influencing how companies spend on automation, cloud and data. The AI Stocks screener focuses on businesses directly tied to this shift, including semiconductors, software, large language models, ChatGPT related tools and cloud infrastructure. This helps you cut through the noise and focus on companies that are closely linked to...

Resolute Mining’s recently released unaudited Q2 2026 operating results showed a steep year-on-year fall in ore mined, ore processed, and gold poured, with quarterly production dropping to 45,192 oz from 151,460 oz. At the same time, the company significantly expanded the Inferred Mineral Resource at its 100%-owned ABC Project in Côte d’Ivoire to 3.02 Moz, highlighting a growing project pipeline even as near-term output weakened. We’ll now examine how the sharp Q2 production drop,...

Elevra Lithium Limited has released its fourth-quarter and full-year operating results to June 2026, showing slightly higher ore mined and processed but lower concentrate production, with recoveries of 71% in Q4 and 67% for the year at a 5.0% concentrate grade. The data highlight that while mining and processing volumes have been broadly steady year-on-year, weaker recoveries have limited concentrate output, which could have important implications for costs and future earnings quality. We’ll...

Retail brands are scrambling to stay relevant as shopper tastes move faster than traditional store formats. The latest Marks & Spencer push into edgier third party lingerie, including Ann Summers, shows how established players try to refresh their image, attract younger customers and create more reasons to visit or click. For investors, that kind of brand rejuvenation can change how a stock is perceived, for better or worse. This article looks at 3 stocks exposed to the same news trend and...

Nuclear energy stocks sit at the crossroads of energy security, inflation concerns and the hunt for reliable long term growth themes. With energy prices feeding into inflation readings across Europe and rate expectations shifting in the US and UK, many investors are looking for sectors that are closely linked to real world demand for power. The Nuclear Energy Stocks screener filters this broad universe into a focused list that highlights producers, reactor operators and related players. In...

High-quality small caps often get ignored while headlines focus on central banks, inflation and energy risks. Yet this is where the High-Quality Undiscovered Gems screener comes in. It filters for smaller companies with solid fundamentals that are not yet widely owned by big funds. In a world where interest rate expectations, commodity moves and mixed growth signals keep markets unsettled, owning businesses with strong balance sheets and disciplined execution can matter more than ever. This...

Penny stocks usually live or die based on one thing: access to cash. In a world where inflation, energy costs, and interest rate expectations are pulling markets in different directions, balance sheet strength matters even more for smaller companies. The Elite Penny Stocks screener focuses only on stocks that still sit in the low price bracket but have the financial backing to pursue their growth targets. For investors hunting for the next potential multi bagger without wanting to sift...

It's been a sad week for Champion Iron Limited ( ASX:CIA ), who've watched their investment drop 13% to AU$3.41 in the...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

AI is no longer just a story about mega caps like Nvidia and Microsoft. With inflation, interest rates and energy costs all in focus, many investors are looking for earlier stage growth where smaller AI stocks can respond quickly to new demand in machine learning, automation and data intelligence. The AI Small Caps screener is designed to surface these focused companies so you can spend less time sorting headlines and more time comparing real business models. In this article you will see...

Critical minerals are back in the spotlight after 3 Proton Lithium revealed what may be America’s largest tungsten deposit in Nevada, an estimated US$152b resource that sits at the crossroads of national security, pricing power and regulation. With tungsten prices already very high since 2025 and U.S. policy support for critical minerals, this kind of discovery can reshape expectations for miners exposed to the story. This article walks through 3 stocks from our Critical Minerals and Mining...

Corporate Travel Management (ASX:CTD) continues to draw investor attention after its recent trading session, with the stock closing at A$16.07. The move highlights how investors are weighing the company’s latest financial profile. See our latest analysis for Corporate Travel Management. Over the past year, Corporate Travel Management has seen its share price return rise 21.10% year to date and its 1 year total shareholder return reach 13.13%, while the 5 year total shareholder return shows a...

CSL (ASX:CSL) has drawn fresh attention after reporting positive top-line Phase 3b results for its hereditary angioedema therapy ANDEMBRY in children aged 2 to 11 years, supporting potential expanded pediatric use. See our latest analysis for CSL. The ANDEMBRY update comes as CSL trades at A$123.06, with a 7 day share price return of 7.74% and a year to date share price decline of 28.44%. The 1 year total shareholder return is down 52.25%, pointing to weak long term momentum despite a recent...